Vir Biotechnology, Inc. Business Finance Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Stock Purchase Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2022
Stock Purchase Agreement between the Company and Glaxo Group Limited, dated February 14, 2021
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2021
Stock Purchase Agreement between the Company and Glaxo Group Limited, dated April 5, 2020
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Form of Underwriting Agreement
Underwriting Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2020
Amendment No. 1 to the Common Stock Issuance Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 17, 2019
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Description of Capital Stock
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
2019 Employee Stock Purchase Plan
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Form of Common Stock Certificate of the Registrant
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Form of Underwriting Agreement
Underwriting Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Securities Purchase Agreement between the Registrant, Humabs BioMed SA, the shareholders of Humabs set forth therein, the option-holders of Humabs set forth therein and Fortis...
Purchase Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Common Stock Issuance Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated October 16, 2017
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
2019 Employee Stock Purchase Plan
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amended and Restated Warrant, issued to Takeda Ventures, Inc
Warrant Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 29, 2017
Investor Rights Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019